Aurobindo Pharma Ltd Financial Overview
Aurobindo Pharma Ltd's market cap is currently ₹668.50B. The company's EPS TTM is ₹14.61; its P/E ratio is 19.71; and it has a dividend yield of 0.34%. Aurobindo Pharma Ltd is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is ₹14.96. See an overview of income statement, balance sheet, and cash flow financials.
